Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q1 2021 · 10-Q
Revenue$46.00K$46.00K+21.1% vs Q1 2020 Net Income-$2.97M-$2.97MN/M vs Q1 2020 EPS Diluted-$0.18-$0.18N/M vs Q1 2020 Operating Income-$2,972,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
Free Cash Flowderived-$1,910,000N/M Margins · derivedOperating margin-6460.9%+5668.1 pt vs Q1 2020
Net margin-6454.3%+5635.1 pt vs Q1 2020
ended Mar 31, 2021 · filed May 13, 2021 · 43 d after period end